Skip to main navigation Skip to search Skip to main content

The potential role of mycotoxins as a contributor to stunting in the SHINE Trial

  • Laura E. Smith
  • , Andrew J. Prendergast
  • , Paul C. Turner
  • , Mduduzi N.N. Mbuya
  • , Kuda Mutasa
  • , George Kembo
  • , Rebecca J. Stoltzfus
  • Queen Mary University of London
  • Zvitambo Institute for Maternal and Child Health Research
  • University of Maryland, College Park
  • Cornell University
  • Food and Nutrition Council of Zimbabwe

Research output: Contribution to journalArticlepeer-review

62 Scopus citations

Abstract

Children in developing countries experience multiple exposures that are harmful to their growth and development. An emerging concern is frequent exposure to mycotoxins that contaminate a wide range of staple foods, including maize and groundnuts. Three mycotoxins are suspected to contribute to poor child health and development: aflatoxin, fumonisin, and deoxynivalenol. We summarize the evidence that mycotoxin exposure is associated with stunting, and propose that the causal pathway may be through environmental enteric dysfunction (EED) and disturbance of the insulin-like growth factor 1 (IGF-1) axis. The objectives of this substudy are to assess the relationship between agricultural and harvest practices and mycotoxin exposure; to evaluate associations between mycotoxin exposure and child stunting; and to investigate EED as a potential pathway linking mycotoxin exposure to child stunting, to inform potential areas for intervention.

Original languageEnglish
Pages (from-to)S733-S737
JournalClinical Infectious Diseases
Volume61
DOIs
StatePublished - Dec 15 2015

Keywords

  • aflatoxin
  • deoxynivalenol
  • fumonisin
  • mycotoxin
  • stunting

Fingerprint

Dive into the research topics of 'The potential role of mycotoxins as a contributor to stunting in the SHINE Trial'. Together they form a unique fingerprint.

Cite this